Long COVID and COVID-19 in children

This wiki is intended for healthcare professionals and should not be considered medical advice.

General
Ludvigsson JF. Case report and systematic review suggest that children may experience similar long‐term effects to adults after clinical COVID‐19 Acta Paediatrica. 2020;00:1–8 doi.org/10.1111/apa.15673

Hobbs CV, Khaitan A, Kirmse BM, Borkowsky W. COVID-19 in Children: A Review and Parallels to Other Hyperinflammatory Syndromes. Front Pediatr. 2020 Nov 24;8:593455. doi: 10.3389/fped.2020.593455. PMID: 33330288; PMCID: PMC7732413.

Useful Organisations

 * Long Covid Kids
 * [Placeholder]

MIRS
Bautista-Rodriguez C. et al. (Nov 2020) Multisystem Inflammatory Syndrome in Children: An International Survey Pediatrics, e2020024554; DOI: https://doi.org/10.1542/peds.2020-024554

ABSTRACT ''Objective. To describe presentation, hospital course and predictors of bad outcome in Multisystem Inflammatory Syndrome in Children (MIS-C).'' ''Methods. Retrospective data review of a case series of children meeting published definition for MIS-C discharged/died between March 1st and June 15th, 2020, from 33 participating European, Asian and American hospitals. Data was collected through a web-based survey and included clinical, laboratory, electrocardiographic and echocardiographic findings and treatment management.'' ''Results. We included 183 patients (109 males [59.6%]; mean age 7.0±4.7 years; black race, 56[30.6%]; obesity, 48[26.2%]) with MIS-C. Overall, 114/183(62.3%) had evidence of SARSCoV-2 infection. All presented with fever, 117/183 (63.9%) with gastrointestinal symptoms and 79/183 (43.2%) with shock, that was associated with black race, higher inflammation and imaging abnormalities. Twenty-seven patients (14.7%) fulfilled criteria for Kawasaki disease. They were younger with no shock, fewer gastrointestinal, cardio-respiratory and neurological symptoms. The remaining 77 patients (49.3%) had mainly fever and inflammation. Inotropic support, mechanical ventilation and ECMO were indicated in 72 (39.3%), 43 (23.5%) and 4 (2.2%) patients, respectively. A shorter duration of symptoms prior to admission was found to be associated with poor patient outcome and for ECMO/death, with 72.3% (95% CI 0.56-0.90, p=0.006) increased risk per day reduction and with 63.3% (95% CI 0.47-0.82, p<0.0001) increased risk per day reduction respectively.'' ''Conclusion. In this case series, children with MIS-C presented with a wide clinical spectrum, including KD-like, life-threatening shock and milder forms with mainly fever and inflammation. A shorter duration of symptoms prior to admission was associated with worse outcome. ''